Glaxo’s China Scandal Exposes Big-Pharma’s Ugly Underworld | New Eastern Outlook

See on Scoop.itprojectbrainsaver

An immense scandal involving pharmaceuticals giant GlaxoSmithKline (GSK) has been unfolding in China over the last year. It centers on a massive bribery operation uncovered by Chinese police that included nearly every aspect of GSK’s business in China. Billions of yuan in bribes were channeled through an immense network to buy off doctors, hospitals, healthcare organizations, and even government officials to boost sales of GSK drugs.

See on